Abstract
Nowadays, resveratrol, a polyphenolic phytoalexin is increasingly included in the formulas of cosmetic products and dermatology as an active ingredient, as a consequence of the well-known health beneficial properties, namely antioxidant, anti-inflammatory, anti-viral and anti-bacterial effects. This important compound can be biosynthesized naturally by plants or by industrial synthetic processes. Apart from its anti-inflammatory and antioxidant effects, a broad spectrum of effects has been attributed to the use of this compound such as anti-aging, skin-whitening, anti-angiogenic, collagen I and III stimulation (in fibroblasts) and estrogen-like effects, as well as the ability to protect cells against hydrogen peroxide-induced oxidative stress and UV-irradiation-mediated cell death. In cosmetology and dermatology has been popular because of its ability to penetrate the skin barrier and its anti-aging activity. In fact, resveratrol as an important impact on the regulation of inflammation and, as consequence, repair-related processes in skin. Furthermore, when administered either topically or orally has been proven to be safe and also to overcome the skin barrier. This review will focus in its potential application on melasma treatment and in photo-aging. Resveratrol chemistry, pharmacology, mechanism of action and evidence of its efficacy as photo skin aging protector and its potential use in melasma is discussed.
Keywords
- resveratrol
- cosmetic
- antiaging
- skin treatments
- biological properties
1. Introduction
1.1 Chemistry and biological properties
Resveratrol (3,4′,5-trihydroxy-
Resveratrol is a compound that presents several important biological properties, Figure 2.
The aim of this study is to show the efficacy and tolerability of resveratrol, that can have a topical application to the face and to determine whether this topical treatment with resveratrol can reduce anti-aging effects by improving skin barrier, and elasticity. In fact, Andrzej et al., 2022 [6] concluded that “resveratrol shows an excellent biocompatibility” representing an interesting and promissing novel therapeutical compound for the cosmetic industry.
2. Pharmacology, toxicity and skin permeation
Orally, and considering its structure, resveratrol is rapidly absorbed from the gastrointestinal tract, but with a low bioavailability because is rapidly metabolized in the liver [2]. In human, its plasma half-life has been reported to be 9.2 ± 0.6 hours [7], resulting not carcinogenic in mouse, without developmental and reproductive toxicity [8]. Another important characteristic from this compound, is that, as already proved, it is non-irritating to skin and eyes and non-sensitizing.
2.1 Possible skin application in melasma and it use in skin photoaging
2.1.1 Antioxidant activity
Skin care formulations are usually based on exogenous antioxidants that cannot be synthesized by our body, like vitamins or phenolic compounds. Some studies referred in Literature, report that resveratrol is able to inhibit UV-induced lipid peroxidation. UV irradiation (UV A and B) and blue light are known to induce the formation of free radicals, reactive oxygen species (ROS; e.g., peroxides, superoxide, hydroxyl radical)
In an
2.1.2 Skin-whitening activity and photoaging protection
One the common clinical characteristic of melasma is the appearance of skin hyperpigmentation mainly in the face [22, 23]. In photoaging hyperpigmentation also occurs by cumulative sun exposure [41]. Resveratrol has the ability to modulate the tyrosinase activity by the inhibition of this enzyme and by acting as a competitive substrate, and thus blocking melanogenesis [42, 43, 44]. This compound also inhibits hyperpigmentation by other different mechanisms of action. According to Newton R. A. et al., 2007 [45], at a transcriptional level, resveratrol inhibits the mRNA expression of tyrosinase, tyrosinase-related proteins (Tyrp1 and Tyrp2), microphthalmia-associated transcription factor (MITF), a major regulator of melanogenesis, and DOPAchrome tautomerase (DCT) in human melanocytes
2.1.3 Anti-inflammatory activity and collagen synthesis stimulation
Both, in melasma and skin aging, a decrease in the quantity of collagen I, III, IV-VII (decrease in collagen I, IV in melasma, and all of them in skin aging) in the dermis and basal membrane has been described. In keratinocytes UV A radiation, ROS can upregulate the AP-1 (activator protein 1) and NF-kB (nuclear factor kappa beta) transcription factors [47, 48]. Their upregulation results in the induction of matrix metalloproteinase activity leading to the interference with intracellular signaling pathways responsible to the expression of genes regulating the process of collagen type I and III, resulting in hypertrophy and degradation of elastin and hyaluronic acid [45, 48, 50]. Resveratrol was found to reduce the expression of AP-1 and NF-kB transcription factors, limiting the degradation process of collagen and elastin in the skin, but also skin inflammation [48, 49, 51, 52]. In addition, resveratrol has been to act as an NF-kB inhibitor [53] which can be activated by ROS playing and important role in the inflammatory response [54, 55].
3. Wound healing potential of resveratrol
Another interesting potential property of this substance is their application to the wound healing process. Wound healing is a natural biological mechanism of repairing tissues after suffering from an injury. After tissue damage Nrf-2 and NF-kB play a crucial role in both inflammation and oxidation processes during wound healing process [56]. On the other hand, it is suggested that ROS in not excessive, low, levels are necessary for the wound healing process to fight against pathogens invading the organism, but not good when are produced in high levels in the tissue [57]. So, a control of the ROS produced by compounds such as Resveratrol knowing its proven anti-oxidant capacity is of interest to reduce the excess of tissue damage [58]. In addition, in a work from 2006 [59] was observed the association of an increase in the expression of the VEFG (Vascular Endotelian Growth Factor)
To sum up, if we take into account the related inhibition of the pro-inflammatory mediators’ expression, the ROS reduction ability, the scavenging properties, the increasing in angiogenesis via increasing VEFG and Sirtuins (Sirt-1), resveratrol seems to be a valuable candidate in order to both regulate and improve the wound healing process after skin damage.
4. Clinical evidence of resveratrol uses in cosmetics
The use of resveratrol in cosmetic formulas has increased in the last 15 years because of its potential biological activities described above. The use of this substance in cosmetic formulas such as a cream containing this active ingredient was studied in the work from Igielska-Kalwat [62]. In this study 20 volunteers were administrated topically on the face a cream composed by 0.007% resveratrol and with placebo (no resveratrol cream). Results after 6 weeks showed that treated patients increased skin hydration and firmness, concluding that resveratrol has moisturizing and tightening effects in skin but also safety without any sign of skin irritation. In a different work from Ferzli G. [63], a resveratrol enriched formulation which combined resveratrol with green tea polyphenols and caffeine, reduced facial redness in 13 of the 16 subjects from this study after 12 weeks study period. The other 3 subjects left were seen only to improve skin quality at the end of this study. In 2014, Farris P. [52] demonstrated also the efficacy of another resveratrol enhanced formulation (1% resveratrol, 0 1% Vitamin E and 0.5% baicalin) in the treatment of photodamaged skin. After a 12 weeks period an improvement in fine lines and wrinkles derived from photo aging processes were observed. In a similar work from 2013 [64] the efficacy on protecting the skin after UV aggression on 15 healthy volunteers was performed. In this study after repetitive UV radiation 1% resveratrol treatment after UV damage showed better protective effect even than other antioxidants alone, and logically better than placebo treated subjects.
In a different study form Moyano J.R. [65] a W/O (water in oil) cream was prepared to optimize the permeability and stability of the trans isomer of the resveratrol and study the elasticity, hydration and luminosity capacity of the formulas in 8 women ranging from 45 to 70 years old during a 30 days trial. Results suggested the efficacy of the resveratrol emulsion produced in all patients tested. The increase in all parameters studied was 20.53%, 49.70% and 6.17% for hydration, elasticity and colorimetry respectively.
5. Conclusions
As conclusion, resveratrol could be potentially effective in the treatment of several skin disorders, including diseases or signs of aging, for example. Several studies have shown important biological activity of resveratrol, especially in reconstituted skin models, skin cell cultures, or in animal models. The high activity, and efficacy, of resveratrol as both an antioxidant and a melanin synthesis inhibitor make this compound as a promising candidate for the treatment and prevention of skin aging. Despite this beneficial influence on the skin aging effects and dermal diseases, resveratrol is also effective in healing of wounds and burns. Exist similarities between melasma and skin aging (and photoaging) in terms of the hyperpigmentation, the basement membrane disruption of the skin, as well as the association with ROS owing to the UV exposure. These similarities would make resveratrol as a promising contributor for their treatment and prevention of melasma. Because the vast majority of the literature refers to the activity of resveratrol to
In our opinion, resveratrol may be able to induce collagen synthesis
Acknowledgments
The authors thanks to Dr. José Rocha from Mesosystem for the development of the pictures.
References
- 1.
Fan E, Zhang K, Zhu M, Wang Q. Obtaining resveratrol: From chemical synthesis to biotechnological production. Mini-Reviews in Organic Chemistry. 2010; 7 (4):272-281 - 2.
Ratz-Łyko A, Arct J. Resveratrol as an active ingredient for cosmetic and dermatological applications: A review. Journal of Cosmetic and Laser Therapy. 2018:1-7. DOI: 10.1080/14764172.2018.1469767 - 3.
Bernard E, Britz-McKibbin P, Gernigon N. Resveratrol photoisomerization: An integrative guided-inquiry experiment. Journal of Chemical Education. 2007; 84 (7):1159-1161 - 4.
Chen X, He H, Wang G, Yang B, Ren W, Ma L, et al. Stereospecific determination of cisand trans-resveratrol in rat plasma by HPLC: Application to pharmacokineticstudies. Biomedical Chromatography. 2007; 21 :257-265 - 5.
Camont L, Cottart C-H, Rhayem Y, Nivet-Antoine V, Djelidi R, Collin F, et al. Simple spectrophotometric assessment of the trans−/cis-resveratrol ratio in aqueous solutions. Analytica Chimica Acta. 2009; 634 :121-128 - 6.
Hecker A. The impact of resveratrol on skin wound healing, scarring, and aging. International Wound Journal. 2022; 19 (1):9-28 - 7.
Walle T, Hsieh R, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition. 2004; 32 :1377-1382 - 8.
Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Research. 2010; 70 :9003-9011 - 9.
Williams LD, Burdock GA, Edwards JA, Beck M, Bausch J. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food and Chemical Toxicology. 2009; 47 :2170-2182 - 10.
Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux JL. Resveratrol bioavailability and toxicity in humans. Molecular Nutrition & Food Research. 2010; 54 (1):7-16 - 11.
Amri A, Chaumeil JC, Sfar S, Charrueau CJ. Administration of resveratrol: What formulation solutions to bioavailability limitations? Journal of Controlled Release. 2012; 158 :182-193 - 12.
Hung CF, Lin YK, Huang ZR, Fang JY. Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biological & Pharmaceutical Bulletin. 2008; 31 :955-962 - 13.
Timmers S, Auwerx J, Schrauwen P. The journey of resveratrol from yeast to human. Aging (Albany NY). 2005; 4 :146-158 - 14.
Abla MJ, Banga AK. Quantification of skin penetration of antioxidants of varying lipophilicity. International Journal of Cosmetic Science. 2013; 35 (1):19-26 - 15.
Borek C. Molecular mechanisms in cancer induction and prevention. Environmental Health Perspectives. 1993; 101 (3):237-245 - 16.
Kuse Y, Ogawa K, Tsuruma K, Shimazawa M, Hara H. Damage of photoreceptor-derived cells in culture induced by light emitting diode-derived blue light. Scientific Reports. 2014; 4 :5223, 1-12 - 17.
Liebel F, Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. The Journal of Investigative Dermatology. 2012; 132 (7):1901-1907 - 18.
Lohan SB et al. Free radicals induced by sunlight in different spectral regions – In vivo versus ex vivo study. Experimental Dermatogology. 2016; 25 :380-385 - 19.
Cai H, Xie Z, Liu G, Sun X, Peng G, Lin B, et al. Isolation, identification and activities of natural antioxidants from callicarpa kwangtungensis chun. PLoS One. 2004; 9 :e93000 - 20.
Handel AC, Handel AC, Miot LD, Miot HA. Melasma: A clinical and epidemiological review. Anais Brasileiros de Dermatologia. 2014; 89 (5):771-782 - 21.
Passeron T. Melasma pathogenesis and influencing factors – An overview of the latest research. JEADV. 2013; 27 (1):5-6 - 22.
Lee A-Y. An updated review of melasma pathogenesis. Dermatologica sinica. 2014; 32 (4):233-239 - 23.
Ogbechie-Godec OA, Elbuluk N. Melasma: An up-to-date comprehensive review. Dermatology and Therapy. 2017; 7 (3):305-318 - 24.
Ichihashi M, Ando H, Yoshida M, Niki Y, Matsui M. Photoaging of the skin. Anti-Aging Medicine. 2009; 6 (6):46-59 - 25.
Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell & Melanoma Research. 2018; 31 (4):461-465 - 26.
Miura T, Muraoka S, Ikeda N, Watanabe M, Fujimoto Y. Antioxidative and prooxidative action of stilbene derivatives. Pharmacology & Toxicology. 2000; 86 :203-208 - 27.
Stojanović S, Sprinz H, Brede O. Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Archives of Biochemistry and Biophysics. 2001; 391 :79-89 - 28.
Yilmaz Y, Toledo RT. Major flavonoids in grape seeds and skins. Antioxidant capacity of catechin, epicatechin, and gallic acid. Journal of Agricultural and Food Chemistry. 2004; 52 :255-260 - 29.
Nouveau S, Agrawal D, Kohli M, Bernerd F, Misra N, Nayak CS. Skin Hyperpigmentation in Indian population: Insights and best practice. Indian Journal of Dermatology. 2016; 61 (5):487-495 - 30.
Chen ML, Li J, Xiao WR, et al. Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006; 31 (5):635-639 - 31.
Carrizzo A, Puca A, Damato A, Marino M, Franco E, Pompeo F, et al. Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism. Hypertension. 2013; 62 :359 - 32.
Weber SU, Thiele JJ, Cross CE, Packer L. Vitamin C, uric acid, and glutathione gradients in murine stratum corneum and their susceptibility to ozone exposure. The Journal of Investigative Dermatology. 1999; 113 (6):1128-1132 - 33.
Baxter RA. Anti-aging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation. Journal of Cosmetic Dermatology. 2008; 7 :2 - 34.
Fang JG, Lu M, Chen ZH, et al. Antioxidant effects of resveratrol and its analogues against the freeradical-induced peroxidation of linoleic acid in micelles. Chemistry. 2002; 8 (18):4191-4198 - 35.
Afaq F, Adhami VM, Ahmad N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicology and Applied Pharmacology. 2003; 186 :28-37 - 36.
Yen GC, Duh PD, Lin CW. Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radical Research. 2003; 37 (5):509-514 - 37.
Ungvari Z, Orosz Z, Rivera A, et al. Resveratrol increases vascular oxidative stress resistance. American Journal of Physiology. Heart and Circulatory Physiology. 2007; 292 (5):12 - 38.
Harikumar KB, Aggarwal BB. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle. 2008; 7 (8):1020-1035 - 39.
Kwon S-H et al. Depigmenting effect of resveratrol is dependent on FOXO3a activation without SIRT1 activation. International Journal of Molecular Sciences. 2017; 18 :1213 - 40.
Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biological & Pharmaceutical Bulletin. 2012; 35 :273 - 41.
Flament F, Bazin R, Laquieze S, Rubert V, Simonpietri E, Piot B. Effect of the sun on visible clinical signs of aging in Caucasian skin. Clinical, Cosmetic and Investigational Dermatology. 2013; 6 :221-232 - 42.
Lee SY, Baek N, Nam T-g. Natural, semisynthetic and synthetic tyrosinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2016; 31 (1):1-13 - 43.
Chang T-S. An updated review of tyrosinase inhibitors. International Journal of Molecular Sciences. 2009; 10 :2440-2475 - 44.
Loizzo MR, Tundis R, Menichini F. Natural and synthetic tyrosinase inhibitors as antibrowning agents: An update. Comprehensive Reviews in Food Science and Food Safety. 2012; 11 :378-398 - 45.
Newton RA, Cook AL, Roberts DW, Leonard JH, Sturm RA. Posttranscriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. The Journal of Investigative Dermatology. 2007; 127 :2216-2227 - 46.
Lee TH, Seo JO, Baek SH, Kim SY. Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in guinea pig skin. Biomolecules & Therapeutics (Seoul). 2014; 22 :35-40 - 47.
Adhami VM, Afaq F, Ahmad N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia. 2003; 5 (1):74-82 - 48.
Kundu JK, Shin YK, Surh YJ. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets. Biochemical Pharmacology. 2006; 72 (11):1506-1515 - 49.
Sen CK, Khanna S, Gordillo G, Bagchi D, Bagchi M, Roy S. Oxygen, oxidants, and antioxidants in wound healing: An emerging paradigm. Annals of the New York Academy of Sciences. 2002; 957 :239-249 - 50.
Petrat F, de Groot H. Protection against severe intestinal ischemia/reperfusion injury in rats by intravenous resveratrol. The Journal of Surgical Research. 2011; 167 (2):29 - 51.
Leighton F, Cuevas A, Guasch V, Perez DD, Strobel P, San MA, et al. Plasma polyphenols and antioxidants, oxidative DNA damage and endothelial function in a diet and wine intervention study in humans. Drugs under Experimental and Clinical Research. 1999; 25 :133 - 52.
Farris P, Krutmann J, Li Y-H, McDaniel D, Krolj Y. Resveratrol: A unique antioxidant offering a multi-mechanistic approach for treating aging skin. Journal of Drugs in Dermatology. 2013; 12 :1389 - 53.
Nam N-H. Naturally occurring NF-Kb inhibitors. Mini-Reviews in Medicinal Chemistry. 2006; 6 :945-951 - 54.
Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology. 2009; 1 (6):a001651 - 55.
Wang T, Zhang X, Jian LJ. The nuclear factor NF-kappaB pathway in inflammation. International Immunopharmacology. 2002; 2 (11):1509-1520 - 56.
Ambrozova N, Ulrichova J, Galandakova A. Models for the study of skin wound healing. The role of Nrf2 and NF-κB. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic. 2017; 161 (1):1-13 - 57.
Cano SM, Lancel S, Boulanger E, Neviere R. Targeting oxidative stress and mitochondrial dysfunction in the treatment of impaired wound healing: A systematic review. Antioxidants. 2018; 7 (8):98 - 58.
Bilgen F, Ural A, Kurutas EB, Bekerecioglu M. The excess of oxidative stress and Raftlin levels on woundn healing. International Wound Journal. 2019; 16 (5):1178-1184 - 59.
Kanno Y et al. Lack ofa2-antiplasmin improves cutaneous wound healing viaover-released vascular endothelial growth factor-inducedangiogenesis in wound lesions. Journal of Thrombosis and Haemostasis. 2006; 4 (7):1602-1610 - 60.
Zhou X, Ruan Q , Ye Z, Chu Z, et al. Resveratrol accelerates wound healing by attenuating oxidative stress-induced impairment of cell proliferation and migration. Burns. 2021; 47 (1):133-139 - 61.
Farris P, Yatskayer M, Chen N, Krol Y, Oresajo C. Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin e for treatment of mild to moderately photodamaged skin. Journal of Drugs in Dermatology. 2014; 13 (12):1467-1472 - 62.
Igielska-Kalwat J, Firlej F, Lewandowska A, Biedziak B. In vivo studies of resveratrol contained in cosmetic emulsions. Acta Biochimica Polonica. 2019; 66 (3):371-374 - 63.
Ferzli G, Patel M, Phrsai N, Brody N. Reduction of facial redness with resveratrol added to topical product containing green tea polyphenols and caffeine. Journal of Drugs in Dermatology. 2013; 12 :770-774 - 64.
Wu Y, Jia LL, Zheng YN, Xu XG, Luo YJ, Wang B, et al. Resveratrate protects human skin from damage due to repetitive ultraviolet irradiation. Journal of the European Academy of Dermatology and Venereology. 2013; 27 :345-350 - 65.
Moyano JR, Fabbrocini G, de Stefano D, Mazzella C. Enhanced antioxidant effect of trans-resveratrol: Potential of binary systems with polyethylene glycol and cyclodextrin. Drug Development and Industrial Pharmacy. 2013; 40 (10):1-8